The ephrins are a family of ligands that bind to Eph family receptor tyrosine kinases, and have been implicated in axon guidance and other patterning processes during vertebrate development. We describe here the identi®cation and characterization of murine ephrin-B3. The cDNA encodes a 340 amino acid transmembrane molecule, most closely related to the two other known transmembrane ligands, ephrin-B1 and ephrin-B2. In addition to homology in their extracellular receptor binding domains, these transmembrane ligands share striking homology between their cytoplasmic domains, with 31 of the last 34 amino acids of ephrin-B3 being identical to ephrin-B2, suggesting functional interactions of the cytoplasmic tail. While most Eph family ligands are promiscuous in their interactions with Eph receptors, binding studies with the ®ve receptors known to bind other transmembrane ligands only revealed a high anity interaction of ephrin-B3 with EphB3, with a dissociation constant of approximately 1 nM. In situ hybridization of mouse embryos showed ephrin-B3 is expressed prominently at the dorsal and ventral midline of the neural tube, particularly in the¯oor plate, a structure with key functions in patterning the nervous system. The isolation of this ligand may help to elucidate the molecular basis of patterning activities at the neural tube midline.
Introduction
The receptor tyrosine kinases can be divided into families based on structural homology, and in some cases obvious similarities in functional properties. While several of these receptor families have been characterized extensively, the Eph family has until recently not been well understood, although it has by far the largest number of known members. Fourteen Eph family receptors have been described, not counting apparent orthologs found in more than one species Eph Nomenclature Committee, 1997; Flanagan and Vanderhaeghen, in press ). Remarkably, every member of the Eph receptor family was initially identi®ed as an orphan receptor without a known ligand. Nevertheless, the distinctive expression patterns of the receptors soon suggested interesting roles in cellcell signaling. Almost all the receptors are expressed prominently in the developing or adult nervous system, suggesting roles in neural development or function (Becker et al., 1994; Cheng and Flanagan, 1994a; Ciossek et al., 1995; Ganju et al., 1994; Henkemeyer et al., 1994; Lai and Lemke, 1991; Maisonpierre et al., 1993; Nieto et al., 1992; Pasquale et al., 1992; Ruiz and Robertson, 1994; Sajjadi and Pasquale, 1993; Soans et al., 1994; Tuzi and Gullick, 1994; Zhou et al., 1994) . Also, many of the receptors are expressed in highly restricted patterns at the stage of gastrulation and organogenesis, suggesting functions in patterning the embryo. For example, many of the receptors display characteristic rhombomere-speci®c patterns in the hindbrain (Becker et al., 1994; Cheng and Flanagan, 1994a; Ganju et al., 1994; Henkemeyer et al., 1994; Nieto et al., 1992; Ruiz and Robertson, 1994) .
More recently, a family of ligands for the Eph receptors has been identi®ed, called the ephrins (Eph Nomenclature Committee, 1997; Flanagan and Vanderhaeghen, in press ). These ligands have so far all been identi®ed based on receptor-binding properties, expression patterns, or sequence homology. Like the receptors, the ligands form a family of molecules sharing close sequence homology. All the ligands described so far exist in membrane associated forms. They can be grouped into two subfamilies based on their sequence homologies, their receptor-binding preferences and their mode of membrane anchorage. The ligands of the ephrin-A subfamily are anchored by a glycosyl phosphatidylinositol (GPI) lipid tail, and are represented by ®ve known ligands. The ephrin-B ligands are anchored by a transmembrane domain and in addition to ephrin-B3, described here, include two other ligands, ephrin-B1 (originally named LERK-2/Elk-L/Cek5-L) (Beckmann et al., 1994; Davis et al., 1994; Shao et al., 1994) and ephrin-B2 (originally named ELF-2/Htk-L) (Bennett et al., 1995; Bergemann et al., 1995) . Recent evidence indicates that receptorligand binding can result in phosphorylation of the transmembrane ligands, indicating bi-directional signal transduction through both the receptor and the ligand (Bruckner et al., 1997; Holland et al., 1996) .
The Eph receptors can also be divided into two subfamilies, based on sequence homologies and ligand binding preferences. The EphA subfamily includes receptors binding preferentially to the ephrin-A ligands, and the EphB subfamily to the ephrin-B ligands. Within each subfamily, binding seems to be relatively promiscuous, with each receptor typically binding at relatively high anity to multiple ligands and vice-versa. For example, both ephrin-B1 and ephrin-B2 can interact at comparable anities with EphB1, EphB2 and EphB3 . It has also been suggested that there might be some functional interaction across subfamilies, since ephrin-B2 binds at moderate anity to EphA4 (Gale et al., 1996b) .
Speci®c actions for the ephrins have now been identi®ed in neural development. They can function as axon guidance molecules, and may act as positional labels in the establishment of topographically ordered axon projection maps (reviewed by Tessier-Lavigne, 1995; Flanagan and Vanderhaeghen, in press ). During development of the retinotectal map of the chick, which projects an image of the visual world from the retina to the tectum of the midbrain, two ligands, ephrin-A2 and ephrin-A5, are expressed in an anteroposterior gradient in the target Drescher et al., 1995) , while their receptor EphA3 is expressed in the projecting retinal neurons, in a gradient along the matching nasotemporal axis . Assays of retinal axon responses have shown appropriate guidance eects: ephrin-A5 can repel retinal axons in vitro (Drescher et al., 1995) with a topographically appropriate preference for temporal axons (Monschau et al., 1997) , while ephrin-A2 can repel retinal axons in vitro and in vivo, also with a topographically appropriate specificity (Nakamoto et al., 1996) . Ephrin-A2, ephrin-A5 and their receptor EphA3 thus have properties consistent with complementary positional axonal mapping labels of the type originally proposed by Sperry (1963) . Axon guidance functions have also been implicated by studies of other developmental systems, including topographic mapping of the hippocamposeptal projection, establishment of tracts across the midline of the brain, and guidance of developing sensory and motor spinal nerves (Donoghue et al., 1996; Gao et al., 1996; Henkemeyer et al., 1996; Kilpatrick et al., 1996; Ohta et al., 1996; Orioli et al., 1996; Zhang et al., 1996; Park et al., 1997; Wang and Anderson, 1997) . The ephrins have also been implicated in the establishment of regional pattern in the nervous system, including the control of neural crest migration, the establishment of rhombomere boundaries in the hindbrain, and the organization of the diencephalon (Krull et al., 1997; Smith et al., 1997; Xu et al., 1995 Xu et al., , 1996 .
Here we describe the identi®cation and characterization of a member of the ephrin family, ephrin-B3. This molecule was described by us as mouse ELF-3 in a separate report containing an assessment of its receptor activation properties , while the human ortholog was independently identi®ed by others as NLERK-2 (Nicola et al., 1996) or Elk-L3 (Gale et al., 1996a) . The sequence of ephrin-B3 indicates it is a transmembrane molecule, with particularly close sequence homology to the other known transmembrane ligands, ephrin-B1 and ephrin-B2. We show that ephrin-B3 binds with nanomolar anity to the receptor EphB3. However, unlike ephrin-B1 and ephrin-B2, it does not appear to show high anity binding to EphB1, EphB2 or EphB4. In situ hybridization analysis of ephrin-B3 expression during organogenesis reveals that by far the strongest expression occurs in the dorsal and ventral midlines of the neural tube. This expression positions ephrin-B3 temporally and spatially so that it could interact with EphB3, which also shows neural expression (Becker et al., 1994; Ciossek et al., 1996) , and suggests possible functions for ephrin-B3 in patterning of the midline of the central nervous system.
Results

Cloning and sequence analysis of ephrin-B3
After we had cloned ephrin-B2 , a search of the computer databases for similar sequences revealed the previously cloned ephrins as obvious homologs. In addition, we noticed in the Human Genome Sciences expressed sequence tag database a 454 bp human cDNA fragment that, when translated, shares 51% identity with ephrin-B2 over a stretch of 89 amino acid residues. To investigate further whether this sequence might represent a new member of the ephrin family, this cDNA was isolated by polymerase chain reaction (PCR) from a human brain cDNA library. The human cDNA PCR product was then used to screen a phage lambda library of cDNAs from newborn mouse brain. Three hybridizing clones were identi®ed. These three clones contain overlapping sequences that appeared to represent a novel cDNA. This cDNA sequence contains an open reading frame that could encode a 340 amino acid polypeptide (Figure 1a ), which we initially named ELF-3, for Eph ligand family-3, and is now renamed ephrin-B3 in the new nomenclature (Eph Nomenclature Committee, 1997) . The open reading frame starts with a methionine codon in a nucleotide sequence context consistent with a translation initiation site (Kozak, 1987) , followed by a predicted signal peptide for secretion (von Heijne, 1984) . The region between amino acid residues 227 and 251 is hydrophobic and is likely to represent a transmembrane domain ( Figures  1a and b) .
The ephrin-B3 deduced amino acid sequence shows close homology to other members of the ephrin family, and includes the four cysteine residues that are conserved in all known members of the family (Figure 1 ). The ephrin-B3 sequence shows particularly close homology to ephrin-B1 and ephrin-B2, the other known transmembrane ligands in the family (Figures 2  and 3 ). However, it is clear that ephrin-B3 represents a distinct new family member, rather than an ortholog, since the ephrin-B1 and ephrin-B2 sequences have previously been reported from both mouse and human (Beckmann et al., 1994; Bennett et al., 1994; Bergemann et al., 1995; Davis et al., 1994; Shao et al., 1994) . A particularly striking aspect of the homology of ephrin-B3 with the other transmembrane ligands is the very close homology in their intracellular domains. In particular, 31 of the last 34 amino acid residues of ephrin-B3 are identical to the corresponding residues in ephrin-B2 (Figure 3 ). The only three dierences in this region are conservative and do not strongly alter the chemical nature of the amino acid residues. In a comparison of ephrin-B1 and ephrin-B2 over this same region, the last 33 amino acids are all identical (Figure 3 ).
During the preparation and review of this manuscript two other groups reported human cDNA sequences with considerable similarity to the mouse ephrin-B3 sequence identi®ed here, called NLERK-2 (Nicola et al., 1996) or Elk-L3 (Gale et al., 1996a) . These human sequences each display 91% identity at the nucleotide level to the 1078 bp mouse sequence reported here, and each encodes a 340 amino acid open reading frame with 96% identity to the mouse polypeptide sequence described here. These close sequence similarities make it likely that the mouse and human sequences are orthologs, and they are now named m-ephrin-B3 and h-ephrin-B3 (Eph Nomenclature Committee, 1997).
Characterization of the binding of ephrin-B3 to Eph family receptors
Ephrin-B3 was tested here for binding to ®ve members of the EphB subfamily of Eph receptors: m-EphB1 (Lhotak et al., 1991), c-EphB2, c-EphB3 (Sajjadi and Pasquale, 1993) , m-EphB4 (Bennett et al., 1994) and cEphB5 (Sajjadi and Pasquale, 1993) , all expressed in stably-transfected NIH3T3 cells as fusion proteins consisting of the receptor extracellular domain fused to the intracellular domain of TrkB. To test for a Figure 2 Dendrogram showing sequence relationships of the ephrin family. The tree was generated using the MEGALIGN program (Hein, 1990) Figure 3 Alignment of ephrin-B3 and other transmembrane ephrin family members. Black boxes indicate majority amino acid residues in two or more sequences at that position. Gray boxes indicate residues that are conservative changes with respect to the residues in the black boxes. Sequences were aligned with the PILEUP program and displayed using the PRETTYBOX program in the UWGCG package binding interaction with these receptors, we fused the ephrin-B3 extracellular domain to an AP tag (Flanagan and Leder, 1990; Cheng and Flanagan, 1994a) to create an ephrin-B3-AP fusion protein. The receptor-expressing cells were then tested for binding of ephrin-B3-AP (Figure 4a ). In repeated experiments, ephrin-B3-AP (at 1 nM concentration) bound at levels signi®cantly above controls only to cell lines expressing the extracellular domain of EphB3; typical results are shown in Figure  4a . Similarly, COS cells transfected with pmELF3C, and therefore expressing cell surface ephrin-B3, bound EphB3-AP, but failed to bind EphB1-AP, EphB2-AP or EphB4-AP fusion proteins signi®cantly above background at 1 nM (data not shown).
To determine the anity of binding of ephrin-B3 for c-EphB3, and also for its murine homolog m-EphB3 (Ciossek et al., 1996) we performed Scatchard analyses. The binding interactions showed reasonably high anities, 3.0 and 1.5 nM for the chicken and mouse receptors respectively, consistent with a biologically signi®cant ligand-receptor interaction (Figure 4c,d) . The somewhat higher anity for the mouse version of the receptor presumably re¯ects evolutionary divergence in the two receptor sequences, with mouse ephrin-B3 and mouse EphB3 constrained to changes that maintain their binding anity.
We also tested ephrin-B3 for binding to EphA4. Although this receptor is in the EphA receptor subclass, it has been reported to bind with moderate anity to ephrin-B2 (Gale et al., 1996b) . At relatively high levels of ephrin-B3-AP (5 nM), reproducible binding above background could be detected to 293T cells transfected with pSEKpCDNA1, encoding EphA4 (Figure 4b ). However, when we attempted to determine the anity of the interaction, the binding curve of ELF3-AP to EphA4 appeared completely linear and showed no sign of approaching saturation at ligand concentrations as high as 6 nM ( Figure 4e ). The interaction of ephrin-B3 with EphA4 is therefore likely to have a relatively low anity, with a K D well in excess of 6 nM. With 5 nM ephrin-B3-AP we were able to detect weak binding to EphB1 and EphB2, but no binding above background to EphA3 (data not shown).
In situ hybridization analysis of ephrin-B3 expression in the mouse embryo Studies of the Eph family receptors and ligands have shown very distinctive expression patterns during early organogenesis in vertebrates, and have provided valuable clues to potential functions. We were therefore interested to test the temporal and spatial expression patterns of ephrin-B3 in the embryo. In situ hybridization analysis of ephrin-B3 RNA in whole mount mouse embryos was performed at days 8.5, and 9.5 and on sections of embryos at days 10.5, 11.5, 12.5, 14 and 16. A similar study has been reported by Gale et al. (1996a) . At day 8.5, by far the strongest expression is concentrated in the¯oor plate of the midbrain and hindbrain (Figure 5a ). There is also weaker expression in the dorsal hindbrain, in rhombomeres 2, 4 and 6. At day 9.5 an essentially similar pattern can be observed with by far the most intense staining remaining in the¯oor plate of the midbrain and hindbrain (Figure 5b) . In situ analysis of cross-sections of later stage embryos clearly establish that ephrin-B3 continues to be expressed in the¯oor plate (Figures 5c ± i) . Sections through day 15 and day 16 embryos also show expression in the dorsal midline of the hindbrain and spinal cord (Figures 5f ± i) . Sections through the forebrain at day 16 show some hybridization, though staining is weaker than in the more posterior regions of the neural tube, and with no obvious localization to midline structures (Figure 5g) .
Discussion
All the members of the Eph family of receptor tyrosine kinases were initially identi®ed as orphan receptors, and none of their ligands were known until the recent identi®cation of the ®rst members of a corresponding ligand family. We report here the isolation of a cDNA encoding a new member of the ephrin family. The molecule encoded by this mouse cDNA, ephrin-B3, shows obvious homology to all the other seven members of the ephrin family, and is most closely related in primary sequence to ephrin-B1 and ephrin-B2.
Every member of the ephrin family so far identi®ed contains a membrane anchorage domain. Five of them, ephrin-A1 through ephrin-A5, are anchored by a GPI lipid tail, a feature not so far identi®ed in any other ligands that bind to receptor tyrosine kinases. In contrast, ephrin-B3 and its close relatives ephrin-B1 and ephrin-B2 have a transmembrane domain. Transmembrane domains have been found in a number of other ligands, including kit ligand (KL), and several members of the epidermal growth factor (EGF) family, such as EGF and transforming growth factor-a (TGF-a) (Massague and Pandiella, 1993) . In the case of KL, genetic evidence indicates that the presence of the transmembrane domain is essential for the normal functioning of the molecule in development (Flanagan et al., 1991) . In general, it is likely that membrane anchorage of these ligands may be important in ensuring a tight localization in tissues. This may be particularly true of the ephrin family, which appear to require membrane anchorage or clustering for activity (Davis et al., 1994) . Thus, while other transmembrane growth factors can be cleaved to generate active soluble forms, ephrin family ligands may be active only when presented at cell surfaces, perhaps helping to ensure an especially precise spatial speci®city in controlling developmental processes such as axon guidance.
The close homology of ephrin-B3 with ephrin-B1 and ephrin-B2 is seen not only in the extracellular receptor-binding domain, but also in the intracellular domain. One feature that the three transmembrane Eph family ligands share with several other transmembrane ligands is a valine residue at the carboxy terminus. A C-terminal valine was shown to be required for the proteolytic cleavage of TGF-a in its extracellular domain (Bosenberg et al., 1992) , though it is not required for the equivalent cleavage of KL (Cheng and Flanagan, 1994b) , and therefore might have some other function. It is also interesting that a C-terminal valine forms part of a short motif that binds PDZ domains (Songyang et al., 1997) , and it will be interesting to see if this is involved in the function of the ephrin-B cytoplasmic tail. Overall, the intracellular domains of the transmembrane Eph family ligands show a strikingly high degree of homology. In particular, 31 of the last 34 amino acids of ephrin-B3 are identical to the comparable residues of ephrin-B1 and ephrin-B2. Obvious intracellular homology of this type has not been observed in other classes of transmembrane ligands for receptor tyrosine kinases.
This very high level of intracellular conservation among the transmembrane Eph family ligands suggests a signi®cant functional role for the cytoplasmic domains of these proteins. One possibility could be a role in regulating the receptor-ligand interaction. For example, in view of the requirement for cell surface presentation or ligand clustering for receptor activation (Davis et al., 1994) , it is possible that the ligand intracellular domain could function to regulate ligand oligomerization. Consistent with a possible role in modulating receptor activation, ephrin-B1 with the intracellular domain removed, but retaining the transmembrane domain, displays an enhanced capacity to stimulate focus formation by an EphB3-TrkB chimeric receptor. Alternative potential functions for the cytoplasmic domains of the transmembrane ligands include cytoskeletal attachment, or transmission of a signal into the interior of the ligand-presenting cell . In relation to all these potential functions, it is interesting that recent studies have indicated receptor binding results in phosphorylation of the transmembrane ligands ephrin-B1 and (Bruckner et al., 1997; Holland et al., 1996) . It is not yet known what the biological function of such transmembrane signaling through the ligand may be, though genetic evidence suggests the possibility that the ephrin-B ligands might transduce an axon guidance signal into the cell that carries them Orioli et al., 1996) .
To investigate the binding of ephrin-B3 to Eph family receptors, we tested ®ve receptors in the EphB subfamily, EphB1 through EphB5. This subfamily of the Eph tyrosine kinases binds ephrin-B1 and ephrin-B2, and is widely regarded as the subfamily of receptors corresponding to the transmembrane ligands Gale et al., 1996b; Eph Nomenclature Committee, 1997; Flanagan and Vanderhaeghen, in press ). We also tested the EphA4 receptor, which has been reported to bind with moderate anity to ephrin-B2 (Gale et al., 1996b) , and the EphA3 receptor. Surprisingly, when we tested ephrin-B3 with all these receptors, a high anity interaction was detected with only one of them, EphB3. Some interaction of ephrin-B3 was detected with EphA4, though the anity appeared to be low. We used receptors derived from mouse in the cases of EphB1, EphB3, EphB4, EphA3 and EphA4, so at least in those cases the dierences in binding cannot be explained by species dierences. In a separate study, human ephrin-B3 was tested for binding to several Eph receptors (though not EphB3) and high concentrations of Fc fusions of EphB1, EphB2 and EphA4 were found to bind to ephrin-B3, although the anities were not reported (Gale et al., 1996a) . The preferential binding of ephrin-B3 to EphB3 that we describe here provides a contrast with ephrin-B1 and ephrin-B2, since each of those ligands binds with similar anity to EphB1, EphB2 and EphB3, all at a K D of approximately 1 nM Gale et al., 1996b) . On the other hand, binding of those ligands is also not entirely promiscuous, since ephrin-B1 binds weakly if at all to EphB4, whereas ephrin-B2 binds well to EphB4 Sakano et al., 1996) . The K D measured here for the interaction of mouse ephrin-B3 with mouse EphB3 is approximately 1.5 nM, within the typical range of anities for ligands binding to their cognate tyrosine kinase receptors.
These studies are consistent with EphB3 being a biologically signi®cant receptor for ephrin-B3. A biologically signi®cant interaction of ephrin-B3 with other known Eph receptors seems less likely on the basis of the binding studies, although it cannot be ruled out. If ephrin-B3 does act through EphB3, it is not yet clear whether this would involve receptor activation, or alternatively whether it might act as an inhibitory or antagonistic ligand, as shown for example in the case of argos, an inhibitory ligand of the Drosophila EGF Receptor tyrosine kinase (Schweitzer et al., 1995) . As part of a separate study, we have tested ephrin-B3 for receptor activation, by assessing focus formation resulting from signaling through a cEphB3-TrkB chimeric receptor . The results show that ephrin-B3 is capable of activating the EphB3-TrkB receptor. On the other hand, prominent focus formation was seen only after deletion of the ephrin-B3 cytoplasmic domain, which is known to cause an increase in the focus formation activity of ephrin-B ligands . This suggests that other receptors for ephrin-B3, yet to be characterized, might play an additional important role in vivo.
Studies of expression patterns provide further information on likely ligand-receptor interactions, and can also indicate potential functions of the ligands and receptors in development. The expression of ephrin-B3 RNA is consistent with roles in organizing the central nervous system. In particular, the strong expression in the neural tube¯oor plate, and additional expression in the roof plate, points to roles in patterning at the midline.
The¯oor plate plays a key role in the patterning of the early vertebrate embryo, and many activities have been identi®ed that originate from this structure. Ephrin-B3 produced at the midline might possibly act as a diusible factor, although in view of the inactivity of soluble truncated versions of the ephrins in vitro (Davis et al., 1994) , it seems more likely to act as a cell surface factor, mediating a contact dependent signal. The¯oor plate exhibits a number of contact dependent activities. For example, the¯oor plate was found to induce explanted midbrain cultures to produce tyrosine hydroxylase, a marker of dopaminergic neurons, in a contact dependent manner (Hynes et al., 1995) . Other contact dependent functions of the¯oor plate relate to axon guidance (Colamarino and Tessier-Lavigne, 1995) . Growth cones of commissural neurons grow ventrally from the dorsal neural tube, reach the¯oor plate and cross it. Once across, the commissural axons do not re-cross, and change direction to run longitudinally along the¯oor plate. Other axons, depending on the vertebrate species, form longitudinal bundles on the ipsilateral side of the¯oor plate without crossing. This behavior of the axons raises at least three possible contact dependent functions of the¯oor plate. First, an activity of the¯oor plate could act as a haptotactic guidance factor for axons as they ascend or descend the longitudinal tracts. Second, an activity may induce changes in growing axons that cause them to recognize the contralateral axon tract, having previously ignored the ipsilateral axon tract. Third, an activity of the¯oor plate may repel axons, and thereby prevent ipsilateral axons from crossing the midline, or prevent contralateral axons from re-crossing. Indeed, recent studies have detected a contact-dependent repellent activity in oor plate (Stoeckli et al., 1997) . In principle, the roof plate expression of ephrin-B3 could similarly act to inhibit axons from crossing to the contralateral side of the neural tube. The idea of a repellent activity for ephrin-B3 is particularly appealing in view of the axon repellent eects shown for several other Eph family ligands: ephrin-A2, ephrin-A5, ephrin-B1 and ephrin-B2 (Drescher et al., 1995; Nakamoto et al., 1996; Wang and Anderson, 1997) .
While it is not yet clear if EphB3 mediates developmental actions of ephrin-B3, this possibility could be consistent with the information available on the receptor. At day 8.5 (4 ± 10 somites) of development, m-EphB3 is expressed in the ventral midbrain, ventro-posterior forebrain and in the third and ®fth rhombomeres (Becker et al., 1994) . In a study of day 16.5 embryos, a very restricted expression pattern for m-EphB3 was observed in the central nervous system, with expression seen in the mantle layer of the medulla, while in the spinal cord expression is in the gray matter mantle layer of the dorsal and ventral horns (Ciossek et al., 1996) . The expression in the gray matter dorsal horns is particularly interesting, as this is the location of the cell bodies of the commissural neurons, consistent with the idea that EphB3 on the projecting commissural axons might recognize arrival at the¯oor plate through detection of ephrin-B3. It is also interesting that targeted mutagenesis of m-EphB3 results in a disruption of speci®c commissures in the forebrain . While it may be dicult to account speci®cally for the forebrain defect in terms of ephrin-B3, which seems to be expressed mainly in more posterior regions, this result supports a role for ligands of EphB3 in axon guidance at the midline.
In view of the importance of the known ligands for receptor tyrosine kinases, it is remarkable that by far the largest known family of receptor tyrosine kinases, the Eph family, should until recently have had no known ligands. The identi®cation of ephrin-B3 and other members of the ephrin family has provided new evidence on the potential roles of this family in development, and will now allow further direct investigations of their biological functions.
Materials and methods
Identi®cation of clones encoding ephrin-B3
The ephrin-B2 amino acid sequence was used to screen for homologs in the DBEST database using the BLAST program (Altschul et al., 1990) , resulting in identi®cation of a fragment of cDNA showing homology to a short stretch of ephrin-B2. This sequence, accession number H10006, had been obtained from a human infant brain cDNA library (Soares et al., 1994) .
To perform further studies, we ampli®ed this sequence from reverse transcribed human brain total RNA (Clontech) by polymerase chain reaction (PCR), using two oligonucleotides: CCCAAACCTTCTTCTCACATGT and GCTGG-GGTCACCTGGTATGGTGT. The resulting 331 bp PCR product was puri®ed by agarose gel electrophoresis, and was then radioactively labeled and used to screen a mouse newborn brain cDNA library by hybridization, with a low stringency wash at 508C in 26SSC. Three hybridizing clones were isolated, E3.1, E3.2, and E3.3. Sequencing revealed E3.1 to contain the complete coding region of a novel Eph family ligand, and E3.2 and E3.3 to be partial clones of the same gene.
Binding assays
The ephrin-B3 expression plasmid, pmELF3C, was constructed by cloning the 3.0 kb HindIII to XbaI fragment of E3.1, containing the entire open reading frame shown in Figure 1 , between the HindIII and XbaI sites of pcDNAI (Invitrogen).
To test for ligand binding to receptors on cell surfaces, the extracellular domain of ephrin-B3 was fused to a placental AP tag. The ephrin-B2 extracellular domain was ampli®ed by PCR, using E3.3 as template, introducing an arti®cial HindIII site at the 5' end (nucleotide 1 of Figure 1 ) and an arti®cial BamHI site at the 3' end of the extracellular domain. This fragment was then inserted between the HindIII and BglII sites of APtag-2, to produce plasmid pmELF3D, encoding a fusion protein with Pro-223 of ephrin-B3 linked to AP through a four amino acid linker (Gly-Ser-Ser-Gly). COS cells were transfected with pmELF3D using Lipofectamine (Gibco BRL), and the production of ephrin-B3-AP protein was monitored by assaying supernatant for heat-stable alkaline phosphatase activity. The production of NIH3T3 cell lines stably producing m-EphB1, c-EphB2, c-EphB3 and c-EphB5 extracellular domains fused to the intracellular domain of trkB, and the NIH3T3 cell line stably expressing mEphB4, have been described . A vector expressing m-EphB3-TrkB was produced through PCR ampli®cation of the extracellular and transmembrane domains of m-EphB3, using the primers ACGCGTC-GACGGGCTATGGCCGGAGCCCGCC and CCATGGC GCTGGCGCCTGAGGCAG. The resulting 1.7 kb product was cloned into pMEX/neo together with 1.2 kb NarI, EcoRI fragment of pRB62 (encoding the intracellular portion of Trk B) for expression of m-EphB3-TrkB in NIH3T3 cells. Transient expression of EphB1, EphA3 and EphA4 expression were achieved using pELK D, pMEK4pCDNA1 and pSEKpCDNA1, respectively, each of which contains the relevant full-length gene cloned into pCDNA1. The reverse binding experiments were performed by testing the binding of c-EphB2-AP, c-EphB5-AP, c-EphB3-AP and m-EphB1-AP fusion proteins to COS cells transfected with pmELF3C. Quantitative studies of receptor-ligand interaction using the binding of soluble AP fusion proteins to cell surfaces were performed as described previously (Flanagan and Leder, 1990; Cheng and Flanagan, 1994a) . Binding is indicated as the AP activity bound to con¯uent cells in a 3.5 cm tissue culture dish.
In situ analysis of ephrin-B3 RNA expression Analysis of ephrin-B3 RNA expression was performed using two dierent probes, both of which revealed the same expression pattern. The ®rst probe was generated by transcription of NcoI-digested E3.1, using T3 RNA polymerase to create a digoxigenin-labeled probe. This created a 600 bp antisense probe to the 3' non-coding region of gene. The second probe was generated by transcription of BglII digested pmELF3C, using SP6 to create a 2.1 kb antisense digoxigenin-labeled probe from base 129 of the nucleotide sequence (Figure 1 ) to the end of the non-coding region. Sense strand controls were created by transcription of the plasmids with T7 RNA polymerase (E3.1) or T3 RNA polymerase (pmELF3C). Labeling of probes with digoxigenin-UTP and in situ hybridization of whole mount embryos were performed as described (Wilkinson and Nieto, 1993) with modi®cations (Cheng and Flanagan, 1994a) . In situ results for ephrin-B3 were determined for at least ®ve embryos from at least two litters for each developmental stage and the results obtained were consistently reproducible.
Nucleotide sequence accession number
The nucleotide sequence of ephrin-B3 cDNA has been submitted to Genbank under the accession number AF025288.
